EUCTR2009-010104-28-IS进行中（未招募）不适用
Effects of hydroxyethyl starch 130/0.4 compared to a balanced crystalloid solution on mortality and kidneyfailure in patients with severe sepsis - The 6S Trial
Dept. of Intensive Care, Rigshopitalet0 个研究点目标入组 800 人开始时间: 2011年9月15日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •All adult patients who
- •·Undergo resuscitation in the ICU
- •·AND fulfilment within the previous 24 hours of the criteria for severe sepsis according to the Society of Critical
- •Care Medicine/American College of Chest Physicians (SCCM/ACCP), see Appendix 1
- •·AND consent is obtainable either from the patient or by proxy (physician and/or next of kin)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 15
排除标准
- •·Age < 18 years
- •·Previously randomised in the 6S trial
- •·Allergy towards hydroxyethyl starch or malic acid
- •·Treatment with > 1000 ml’s of any synthetic colloid within the last 24 hours prior to randomisation
- •·Any form of renal replacement therapy
- •·Acute burn injury > 10% body surface area
- •·Severe hyperkalaemia, p-K > 6.0 mM
- •·Liver or kidney transplantation during current hospital admission
- •·Intracranial bleeding within current hospitalisation
- •·Enrolment into another ICU trial of drugs with potential action on circulation, renal function or coagulation
- •·Withdrawal of active therapy
研究者
相似试验
进行中（未招募）
1 期
Effects of hydroxyethyl starch 130/0.4 compared to a balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis - The 6S TrialSevere sepsis or septic shockMedDRA version: 9.1Level: LLTClassification code 10040070Term: Septic shockMedDRA version: 9.1Level: LLTClassification code 10053879Term: Sepsis syndromeEUCTR2009-010104-28-FIDept. of Intensive Care, Rigshospitalet800
进行中（未招募）
不适用
Effects of hydroxyethyl starch 130/0.4 compared to a balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis - The 6S TrialSevere sepsis or septic shockMedDRA version: 13.1Level: PTClassification code 10040070Term: Septic shockSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 13.1Level: PTClassification code 10053879Term: Sepsis syndromeSystem Organ Class: 10021881 - Infections and infestationsEUCTR2009-010104-28-DKDept. of Intensive Care, Rigshospitalet800
已完成
不适用
Efficacy of hydroxyethyl starch (HES) 130/0.4 versus glucose solution in haemodilution therapy of idiopathic sudden hearing loss: a dose-finding, double-blind multicentre trialSudden hearing lossEar, Nose and ThroatISRCTN26222607Fresenius Kabi Deutschland GmbH (Germany)210
尚未招募
不适用
Effect of Hydroxyethyl Starch (Voluven 130/0.4) on Bloof Glucose Levels during Othtopaedic Lower Limb Surgery Under Spinal AnaesthesiaPACTR201710002591405Walter Sisulu University140
已完成
不适用
Intravenous colloid infusions for prevention of pain on propofol injectioCTRI/2020/05/025000Dr Satyajeet Misra128